Delivery Order SPE2DB22D3301-SPE2DB26FX3UY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Remifentanil 5 mg vials under a firm fixed-price contract valued at $19,618.24, with an ultimate completion date of October 23, 2025. This non-competitive, non-set-aside delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The award is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,238.43 delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials under a firm fixed-price contract structure. The award, issued on October 22, 2025, with an ultimate completion date of October 23, 2025, represents a competitively awarded procurement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,919.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This competitively awarded contract, which has no set-aside designation, was executed on July 9, 2025, with an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with a ceiling value of $1,422.92. This order was competitively awarded without set-aside designation and carries a firm fixed price contract type with an ultimate completion date of September 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,466.92 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials. This contract, awarded on October 17, 2025, with an ultimate completion date of October 20, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Remifentanil is a potent opioid analgesic commonly used in...
- The Defense Logistics Agency awarded a delivery order valued at $2,925.36 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This contract type represents a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Remifentanil 2 mg vials with a ceiling value of $1,675.46. The contract utilizes a firm fixed price structure and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials under a firm fixed-price contract. This award, issued on August 28, 2025, carries a ceiling value of $10,266.97 and is expected to reach ultimate completion on August 29, 2025. The contract is a non-set-aside, competitively awarded delivery order that leverages AmerisourceBergen's broader relationship with DLA to fulfill critical pharmaceutical needs. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials under a firm fixed-price contract. The award, issued on August 11, 2025, carries a ceiling value of $7,572.90 with an ultimate completion date of August 12, 2025. This delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Remifentanil is a potent synthetic opioid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Remifentanil 5 mg vials with a ceiling value of $27,502.30. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a competitively awarded, non-set-aside procurement with place of performance in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3UYDelivery Order
The Defense Logistics Agency awarded a $7,618.45 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Remifentanil 2 mg vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of October 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies essential medications across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems. Remifentanil, an opioid analgesic commonly used in medical settings for pain management and anesthesia support, represents the type of specialized pharmaceutical commodity routinely procured through the company's federal contract portfolio. The award carries no set-aside designation, demonstrating AmerisourceBergen's capability to compete successfully for federal medical supply requirements in an open competitive environment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 10/24/25 |